More Business Wire
View Older Stories View Newer Stories-
Appointment of Francis Van Parys as Chief Executive Officer
-
PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
-
Hoffmann Green Cement Technologies and E.C.B.L. Strengthen Their Partnership to Accelerate Decarbonized Construction in Charente-Maritime
-
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 2026
-
BigBear.ai Expands to Middle East with UAE Office to Advance AI Innovation for Global Security
-
3D Investment Releases a Presentation Highlighting Management Issues at SQEX Holdings and Seeks Shareholder Views
-
Sensorion Reports Independent Data Monitoring Committee Raises No Safety Concerns and Agrees to Continue SENS-501’s Audiogene Phase 1/2 Trial
-
HAFNIA LIMITED: Ex Dividend USD 0.1470 on the Oslo Stock Exchange Today
-
Galderma Welcomes Increased Equity Investment From L’Oréal
-
HTC VIVERSE Hits 1 Million Users, Announces Winners of First Global “Spark” Hackathon: Games, Immersive Storytelling, Social Experiences
-
AppLovin to Participate in the Nasdaq 53rd Investor Conference Held in Association with Morgan Stanley
-
TAS Logistyka Expands at CTPark Warsaw South
-
Cool Company Ltd Announces Updated Record Date for Special Meeting for Proposed Merger with Newly Formed, Wholly Owned Subsidiary of EPS Ventures Ltd
-
Resecurity Joined the U.S.-Saudi Business Council as a Chairman's Circle Member
-
China Eastern Airlines Launches New 'Shanghai–Auckland–Buenos Aires' Route, Building 'Air Bridge' on Pacific
-
Hercules Pharmaceuticals Approved as Authorized Distributor in Apexus 340B Prime Vendor Program
-
Airwallex Raises $330M Series G at $8B Valuation, Establishes San Francisco as Dual Global Headquarters
-
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection
-
Rio Tinto’s first Pilbara-made rail car built by Gemco in Karratha
-
FPT Strengthens South Korea Footprint with Strategic Partnership and Investment in Blueward
-
Hotel Okura to Open The Okura Resort Hakone Gora in 2029
-
GoTyme Bank Launches Crypto Trading in the Philippines in Partnership with Alpaca
-
Edgewater Wireless Announces Completion of Eleventh and Twelfth Payments of Debenture Interest
-
Turnbull & Asser Appoints Roberto Menichetti as Creative Director
-
Gigaphoton Excimer Laser for Advanced Packaging Installed at Japanese Company
-
Sustainability Focus Session 2025
-
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies
-
Panah Master Fund Counters M&A Capital Partners’ Rebuttal to its Previously Submitted Shareholder Proposals
-
Gartner Announces Gartner Finance Symposium/Xpo 2026 in Sydney
-
Hemato-Oncology Trials: AOP Health Presents New Results at Top Congress ASH
-
Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025
-
Incyte’s First-in-Class mutCALR-Targeted Monoclonal Antibody, INCA033989, Granted Breakthrough Therapy Designation by U.S. FDA
-
Yescarta® Delivers Consistent Safety, Efficacy, and Quality of Life Benefits Across Broad Range of Relapsed/Refractory Large B-cell Lymphoma Patients in New Analysis at ASH 2025
-
Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R²) in Patients with Relap
-
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future
-
Zai Lab Announces Updates to China’s National Reimbursement Drug List
-
Memphis Shines as Thousands Unite for St. Jude Memphis Marathon Weekend
-
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
-
Star Therapeutics Presents Interim Data from Phase 1/2 Multidose Study of VGA039 in Von Willebrand Disease, Demonstrating Substantial Bleed Reductions in All Patients, at ASH Annual Meeting
-
TheOther Debuts Premium Matcha at an Intimate Art Basel Celebration in Miami Co-Hosted By Central Cee
-
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel’s Opportunity in Relapsed or Refractory Multiple Myeloma
-
Kite’s Next-Generation Bicistronic CAR T-Cell Therapies Show Encouraging Phase 1 Results in Relapsed/Refractory B-Cell Lymphoma in New Data at ASH 2025
-
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
-
Worthington Steel Issues Statement Regarding Klöckner & Co SE
-
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera
-
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting
-
Orca Bio Presents New Clinical Data on Orca-T® in Older Patients Using Reduced Intensity Conditioning Plus New Analyses from the Precision-T Phase 3 Study at the 67th ASH Annual Meeting
-
NMDP℠ Demonstrates Scientific Leadership in Expanding Patient Access to Lifesaving Cell Therapy at ASH 2025
-
ReAlta Announces Promising Phase 2 Data Demonstrating Rapid Clinical Responses and Target Engagement in Steroid-Refractory Acute GvHD at the ASH 2025 Annual Meeting
-
Genetix Participates in the American Society of Hematology’s (ASH) Exclusive Press Program & Shares Recent Patient Experience Data from U.S. Commercial Gene Therapy Implementation
